Top Health Tech Companies in Dublin (91)
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Strong Hiring & Retention: Employee headcount is increasing over the 2023–2026 period, indicating ongoing hiring momentum. Feedback suggests workforce expansion is sustained even if the pace has moderated recently.
Market Expansion: A new Jakarta office was opened in 2026 to deepen engagement across Southeast Asia. Operations span dozens of offices in many countries, supporting customers in more than 80 countries.
Innovation-Driven Growth: New offerings such as the Data Studio AI Assistant and continued development of healthcare interoperability products point to active product investment. Feedback suggests AI and healthcare enhancements are a current strategic focus.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Profitability: Operating earnings and margins improved notably in 2026, with Q3 operating earnings up sharply year over year and the operating margin rising to 5.6%. Feedback suggests earnings resilience is being supported by operational changes and a shifting business mix.
Strong Revenue Growth: Reported annual revenue expanded from $226.6B in 2023 to $270.6B in 2025, including roughly 12% growth in 2024 and 7% in 2025. This establishes a robust multi‑year revenue trajectory even as recent growth rates have moderated.
Cost & Operational Efficiency: Cost controls and operational improvements are described as lifting earnings despite lower revenue in 2026. Optum Health’s operating earnings rose from $41M to $735M year over year while serving fewer value‑based patients, indicating stronger execution.
Brennan & Co Group is an Ireland-based supplier and service provider of equipment, reagents, consumables, and supply-chain management. Founded in Dublin, the group serves the Life Sciences, Healthcare, Industrial, and Pharmacy sectors across Ireland, Europe, and Asia. It comprises Brennan & Co and three related companies, combining specialized technological products with servicing and supply-chain expertise for customers in technical and...
SCOPE is a Healthcare & Pharmaceuticals company with locations in Ireland, UK and USA that is dedicated to providing Healthcare Professionals & patients with high quality, effective and innovative products. Our family has been working within the healthcare sector in Ireland & UK for over 80 years. With this heritage Scope was founded by John and Tom Freyne in 2009. What...
At ABC Fitness, we're passionate about fitness. We believe that everyone deserves the opportunity to be their best selves and live their best lives. Our technology solutions are designed to empower fitness businesses and individuals to achieve their goals, whether it's building a stronger community, streamlining operations, or providing personalized training experiences. We're committed to making fitness accessible and enjoyable...
ABC Fitness Solutions's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests ABC holds a leading position for enterprise gyms and payments at scale, reinforced by multi-platform coverage across operators. External mentions of leadership and large-scale operations indicate durable competitive presence in core segments.
Market Expansion: Feedback suggests ABC has expanded globally with usage in over 100 countries and strengthened regional presence in Latin America via EVO. Partnerships with major franchises and international brands further extend its footprint.
Innovation-Driven Growth: Feedback suggests ongoing product innovation—AI-powered operating infrastructure, new CRM/BI releases, and deeper cross-product integrations—is propelling growth. Regular launches across Ignite, Glofox, Trainerize, and EVO point to a forward-leaning roadmap.
ABC Glofox is on a mission to build a healthier world. We are a venture-backed product-led SaaS company that is in hyper-growth. Along with our ever-growing client base that spans over 60 countries, our team is dedicated to powering the fitness industry with digital solutions. We are one team consisting of honest, moral, and ethical individuals who are heard and...
Connected Health is a Northern Ireland homecare provider delivering high-quality private healthcare services in people’s homes and communities. Its services support independent living through personalised personal care, lifestyle assistance, companionship, dementia care, and hospital-to-home re-enablement. The organisation also uses technology-enabled care, training, and coordinated support to improve wellbeing, prevent ill health, reduce avoidable hospitalisation, and support clients and families.
Fettle is a digital behavioral healthcare company. We provide clients easy access to a diverse range of qualified and insured mental health professionals. Fettle was founded with the ideal that mental health is a universal need and that everyone struggles sometimes. Using technology and data science coupled with a human touch; Fettle enables seamless virtual delivery of mental health support....
The Wellola team believes only the sickest of the sick should be hospitalised and that the future of healthcare is preventative, community-based and supported by digital tools. Wellola prides itself in being highly user-focused, reliable, robust and easy-to-use. Our team have unique, in-depth sector know-how, our pricing model is extremely cost effective and our business model is scalable for national...
Centene provides healthcare solutions to individuals across the United States with more than 23 million members nationwide.
Centene Corporation's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising with multiple quarters of year-over-year increases, a higher 2025 premium and service revenue outlook, and record trailing-twelve-month totals.
Strong Market Position & Advantage: The company is the largest Medicaid managed care organization and the leading ACA Marketplace carrier, with nationwide operations and sustained industry recognition.
Market Expansion: Membership is growing in the ACA Marketplace and Medicare prescription drug plans, alongside ongoing footprint expansion and key state Medicaid contract wins.
We at SiSú believe in ‘getting the good in’. Our vision is to improve the wellbeing of people everyday by offering our customers naturally great tasting healthy products. A small step in Nurturing a Healthier You. A trusted clean brand known for healthy nourishment and great taste
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for...
Becton Dickinson's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is repeatedly described as a leader across core categories like syringes, prefillable drug-delivery systems, blood collection, and infusion therapy, supported by broad global reach and large installed bases. This entrenched position aids customer stickiness and supports durable demand.
Resilient & Sustainable Growth: A substantial portion of revenue comes from everyday consumables and recurring platforms, which provides steadier sales through cycles. Consistent year-over-year revenue increases and diversified end-market exposure underpin an enduring growth profile.
Future-Ready Strategy: Management is reshaping the portfolio into a pure-play MedTech company and investing in manufacturing capacity and innovation to sharpen focus on higher-value growth areas. Guidance reaffirmations and targeted segment investments indicate disciplined execution toward long-term expansion.
We save lives by ensuring that patients get the best test first. xRefer, our smart radiology referral platform, is now live
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of...
Bristol Myers Squibb's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests BMS holds a top‑tier global position with anchor franchises like Eliquis and Opdivo and a broad oncology footprint including cell therapies, reinforcing sustained competitive advantage.
Product Line Growth: Feedback suggests the company’s “growth portfolio” of newer medicines is expanding strongly, with assets such as Reblozyl, Breyanzi, Camzyos, Opdualag and Cobenfy helping to offset legacy declines.
Future-Ready Strategy: Feedback suggests recent acquisitions and collaborations (Karuna/Cobenfy, RayzeBio, Mirati, BioNTech) broaden modalities and late‑decade growth drivers, positioning the company to sustain leadership beyond current headwinds.
Opsona Therapeutics is a leading drug development company specialising in the human immune system. Opsona is identifying new ways to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases. Opsona's drug discovery & development is focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signalling in human immunology. Since 2004, Opsona has also developed a unique and advanced pipeline...
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease
seamlessCARE Ltd. develops innovative assistive technologies that are grounded in years of health care, industry and academic research. Empathic app and API interprets the emotions of non-verbal people. This is the first of many technologies to enhance the lives of adults and children with complex needs.
Zevo Health: Elevating Global Workplace Wellbeing Zevo Health is your partner in advancing workplace wellbeing worldwide. With a steadfast commitment to supporting professionals across diverse industries across the globe, we have developed a multifaceted approach empowers individuals and organizations to thrive. 1. Professional Services and Coaching: Our comprehensive suite of professional services and coaching, available onsite and online, spans mental...
Web Summit is a global technology conference company that organizes large-scale events. Its mission is to create software that enables meaningful connections between CEOs, founders, investors, media, politicians, and cultural figureheads who are reshaping the world. The company hosts major events in cities like Lisbon, Rio de Janeiro, Doha, and Vancouver, serving as a premier marketplace for the global tech...
Ipsen is a French leading global mid-size biopharmaceutical company headquartered in Paris, France focusing its efforts where unmet medical needs are greatest. Ipsen develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Rare Disease and Neuroscience. We have over 5000 employees worldwide and our medicines are registered in more than 100 countries, with direct commercial presence in...
Ipsen's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results show double-digit growth at constant exchange rates in 2024 and 2025 with an accelerated start in Q1 2026, and guidance indicates continued expansion in 2026. This momentum spans all three therapeutic areas rather than a single product.
Profitability: Disclosures highlight expanding core operating margins above the mid-30s and rising core operating income. Guidance continues to target strong margins alongside growth.
Diversified Revenue Streams: Recent updates indicate contributions from Oncology, Rare Disease, and Neuroscience, with products excluding Somatuline growing strongly and rare disease accelerating. Strategic acquisitions and partnerships have broadened the base beyond any single legacy brand.
